For the quarter ended March 2025, Plexus (PLXS) reported revenue of $980.17 million, up 1.4% over the same period last year. EPS came in at $1.66, compared to $0.94 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $980.47 million, representing a surprise of -0.03%. The company delivered an EPS surprise of +7.79%, with the consensus EPS estimate being $1.54.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Plexus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Market Sector- Healthcare/Life Sciences: $411 million versus the two-analyst average estimate of $407.10 million. The reported number represents a year-over-year change of +8.4%.
- Revenue- Market Sector- Aerospace/Defense: $172 million versus $174.10 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +1.2% change.
- Revenue- Market Sector- Industrial: $397 million versus $399.55 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -5% change.
View all Key Company Metrics for Plexus here>>>
Shares of Plexus have returned -6.1% over the past month versus the Zacks S&P 500 composite's -6.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Plexus Corp. (PLXS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
